Stay updated on Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 is now displayed on the page, replacing the previous Revision: v3.3.1.SummaryDifference0.1%

- Check21 days agoChange DetectedThe Publications section now notes that items are automatically filled from PubMed and may not be about the study. The revision tag has been updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedNotice about government funding and potential delays has been removed from the page. The study details and navigation remain unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedA Publications section with recent articles about the trial and IPD sharing information was added; core study details, eligibility criteria, and endpoints remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference2%

- Check79 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.